<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05114200</url>
  </required_header>
  <id_info>
    <org_study_id>2021/467</org_study_id>
    <nct_id>NCT05114200</nct_id>
  </id_info>
  <brief_title>Evaluation of Drug Spread in Ultrasound-Guided Erector Spina Plane Block With Fluoroscopy</brief_title>
  <official_title>Evaluation of Drug Spread in Ultrasound-Guided Erector Spina Plane Block With Fluoroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the injectate spread in erector spinae plane blocks&#xD;
      under fluoroscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be carried out between March 2021 and June 2021 in Istanbul University&#xD;
      Istanbul Medical Faculty Pain Medicine Clinic. Patients who undergone erector spinae plane&#xD;
      block for any indication over the age of 18 will be included in the study.&#xD;
&#xD;
      All procedures will be performed in the operating room under standard monitorization (ECG,&#xD;
      pulse oximetry, non-invasive blood pressure) and all patients will be in the prone position.&#xD;
      The application area will be sterilized with povidone-iodine solution. Mild sedation will be&#xD;
      achieved by using 1-2 mg of midazolam and 50-75 µg of fentanyl iv. The target area will be&#xD;
      visualized by General Electrics (GE) Logiq e Ultrasound device using a 10-12 MHz linear probe&#xD;
      or 1-4 MHz curvilinear probe. Transverse processes and erector spina muscles will be&#xD;
      visualised at the target vertebral level. After local anesthesia (1-2 cc 2% lidocaine), a 20&#xD;
      gauge spinal needle will be inserted using the &quot;in-plane technique&quot;. The needle will be&#xD;
      advanced to the transverse process, after it's position is confirmed with hydrodissection, a&#xD;
      solution of 40 mg triamcinolone, 10 ml 0,5% bupivacaine, 10 ml radiopaque contrast agent will&#xD;
      be injected. Contrast spread will be evaluated with the fluoroscopy in the anterior-posterior&#xD;
      and lateral positions immediately and 30 minutes after the procedure. The level of contrast&#xD;
      radiating in the AP plane and passing through the paravertebral space and the epidural&#xD;
      distance in the lateral plane will be noted. In addition, sensory examination with a pin&#xD;
      prick test will be performed to determine the presence of dermatomal hypoalgesia and/or&#xD;
      analgesia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Actual">June 30, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The level of contrast spread in the anteroposterior plane</measure>
    <time_frame>0 minutes</time_frame>
    <description>Fluoroscopic images will be taken in the anteroposterior plane, number of vertebral levels the injectate has spread out will be recorded.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The level of contrast spread in the anteroposterior plane</measure>
    <time_frame>30 minutes</time_frame>
    <description>Fluoroscopic images will be taken in the anteroposterior plane, number of vertebral levels the injectate has spread out will be recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Contrast spread to paravertebral space</measure>
    <time_frame>0 minutes</time_frame>
    <description>Fluoroscopic images will be taken in the anteroposterior and lateral plane, and contrast spread to the paravertebral space will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast spread to paravertebral space</measure>
    <time_frame>30 minutes</time_frame>
    <description>Fluoroscopic images will be taken in the anteroposterior and lateral plane, and contrast spread to the paravertebral space will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast spread to epidural area</measure>
    <time_frame>0 minutes</time_frame>
    <description>Fluoroscopic images will be taken in the anteroposterior and lateral planes, and contrast spread to the epidural area will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast spread to epidural area</measure>
    <time_frame>30 minutes</time_frame>
    <description>Fluoroscopic images will be taken in the anteroposterior and lateral planes, and contrast spread to the epidural area will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pinprick test</measure>
    <time_frame>0 minutes</time_frame>
    <description>Pinprick test will be performed to determine hypoalgesia and/or analgesia in relevant dermatomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pinprick test</measure>
    <time_frame>30 minutes</time_frame>
    <description>Pinprick test will be performed to determine hypoalgesia and/or analgesia in relevant dermatomes</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Pain, Myofacial</condition>
  <condition>Back Pain</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
    <description>erector spinae plane block applied patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erector spinae plane block</intervention_name>
    <description>Patients will be placed in prone position. Mild sedation will be achieved by using 1-2 mg of midazolam and 50-75 µg of fentanyl iv. The application area will be visualized with General Electrics (GE) Logiq e Ultrasound device using 10-12 MHz linear probe or convex probe. Transverse process and erector spinae muscles will be visualised at the target vertebral level. Following local anesthesia (1-2 cc 2% lidocaine) application to the insertion site, a 20 gauge spinal needle will be inserted using the &quot;in-plane&quot; technique. The needle will be advanced up to the transverse process under ultrasound guidance. After confirming needle position with hydrodissection, 40 mg triamcinolone, 10 cc 0,5% bupivacaine, 10 cc radiopaque contrast agent solution will be injected. Imaging will performed in AP and lateral positions with fluoroscopy immediately and 30 minutes after the injection to evaluate intectate spread.</description>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent erector spinae plane block for any reasons&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age over 18 years old&#xD;
&#xD;
          2. Patients who underwent erector spinae plane block for any reasons&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Age under the age of 18&#xD;
&#xD;
          2. Patients without a clear contrast spread under fluoroscopy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Halil Cetingok, Ass. Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul University Istanbul faculty of medicine department of pain medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Halil Cetingok</name>
      <address>
        <city>Istanbul</city>
        <state>Fatih</state>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 28, 2021</study_first_submitted>
  <study_first_submitted_qc>November 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2021</study_first_posted>
  <last_update_submitted>November 6, 2021</last_update_submitted>
  <last_update_submitted_qc>November 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Halil Cetingok</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Erector spinae plane block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facial Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

